Dietary inflammation, gut microbiome, and muscle loss in older adults
Exploring the Relationship of Diets Inflammatory, Gut Microbiota, and Sarcopenia: A Cross-Sectional Study
This project will test whether inflammatory features of people's diets are linked to changes in gut bacteria and to muscle loss in community-dwelling adults aged 60 and over.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 1220 (estimated) |
| Ages | 60 Years and up |
| Sex | All |
| Sponsor | LanZhou University Academic / other |
| Locations | 1 site (Lanzhou, Gansu) |
| Trial ID | NCT07211321 on ClinicalTrials.gov |
What this trial studies
This cross-sectional observational project will recruit community-dwelling adults aged 60 and older in Lanzhou and collect dietary information, stool samples for gut microbiota sequencing, and muscle function measures including bioelectrical impedance analysis, gait speed, and handgrip strength. Researchers will calculate a dietary inflammatory index from reported intake and characterize gut microbial diversity and composition using sequencing-based methods. They will analyze associations between dietary inflammatory potential, microbial profiles, and sarcopenia status and test whether gut microbiota features mediate the link between diet-driven inflammation and muscle loss. Participants with pacemakers, severe mobility or cognitive impairment, chronic diseases that limit dietary intake, or medications affecting muscle function will be excluded to ensure reliable measurements.
Who should consider this trial
Good fit: Ideal candidates are community-dwelling adults aged 60 or older who have lived in the community for more than five years and can complete gait, handgrip, and BIA testing and are not taking medications that affect muscle function.
Not a fit: People with severe mobility or cognitive impairment, cardiac pacemakers, chronic conditions that limit dietary intake, or those taking medications that affect muscle function are unlikely to participate or receive direct benefit from this observational study.
Why it matters
Potential benefit: If successful, the findings could identify dietary or microbiome targets to help prevent or slow age-related muscle loss.
How similar studies have performed: There is growing evidence linking diet-driven inflammation and the gut microbiota to muscle health, but demonstration of specific microbial mediators of sarcopenia remains an emerging and not-yet-established area.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Permanent residents of the community aged 60 years or older. * Continuous residence duration in the community for more than 5 years. Exclusion Criteria: * Taking medications known to affect muscle function (e.g., corticosteroids, protein supplements, muscle enhancers). * Requiring walking assistance or having severe cognitive impairment that would preclude successful completion of assessments including bioelectrical impedance analysis (BIA), gait speed measurement, and handgrip strength testing. * Presence of a cardiac pacemaker, which contraindicates BIA measurement. * Diagnosis of one or more chronic diseases that significantly limit dietary intake.
Where this trial is running
Lanzhou, Gansu
- Lanzhou university — Lanzhou, Gansu, China (Recruiting)
Study contacts
- Study coordinator: Jianhua Ma Doctor of Medicine
- Email: majianhua@lzu.edu.cn
- Phone: 0086 18993157029
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.